MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Venus Concept Market Cap 2011-2026 | VERO
As of March 17, 2026 Venus Concept has a market cap of $ 726 K
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.84 M | 386 K | 748 K | 92.6 M | 69.6 M | 62.3 M | 29.8 M | 153 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 153 M | 386 K | 51.3 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
3.03 M | $ 2.22 | 5.21 % | $ 3.47 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 10.45 | 0.29 % | $ 1.41 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
661 M | $ 8.36 | -0.24 % | $ 600 M |  Israel |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 37.34 | -0.16 % | $ 1.16 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Butterfly Network
BFLY
|
766 M | $ 4.27 | 9.21 % | $ 904 M | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 13.05 | 3.57 % | $ 1.96 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Establishment Labs Holdings
ESTA
|
2.31 B | $ 65.01 | 2.41 % | $ 1.93 B |  Costa-rica |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 71.2 | 2.02 % | $ 105 B | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.68 | 4.61 % | $ 37 M | USA |
 |
EDAP TMS S.A.
EDAP
|
60 M | $ 4.06 | 2.53 % | $ 151 M |  France |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
466 M | $ 11.16 | 1.18 % | $ 302 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.33 | - | $ 21.5 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.45 | 0.16 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.17 | -0.91 % | $ 1.32 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 62.43 | 1.63 % | $ 3.41 B |  Britain |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
InMode Ltd.
INMD
|
928 M | $ 13.65 | 1.64 % | $ 882 M | Israel |
 |
MiMedx Group
MDXG
|
779 M | $ 4.36 | -1.13 % | $ 644 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
196 B | $ 110.71 | 0.69 % | $ 193 B | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 9.74 | -0.71 % | $ 349 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
258 M | $ 2.6 | 0.39 % | $ 153 M | Israel |
 |
Bio-Rad Laboratories
BIO
|
7.81 B | $ 269.48 | 3.15 % | $ 7.6 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 9.1 | 1.0 % | $ 701 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 32.75 | -0.27 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 176.12 | 3.94 % | $ 13.2 B | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 33.74 | 2.99 % | $ 5.03 K | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
142 M | $ 3.74 | 1.91 % | $ 154 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 17.21 | 0.58 % | $ 404 M | USA |